All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 1, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory front for April 22, 2020

April 22, 2020
No Comments
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Predictive Technology Group, SC Worx, Spectrum DNA.
Read More

Regulatory action for April 22, 2020

April 22, 2020
No Comments
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Life Spine, Mobidiag, Seegene.
Read More

Other news to note for April 22, 2020

April 22, 2020
No Comments
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aetion, Akili, Aptar, Avacta, Bioclinica, C3.ai, CDISC, Centerline Biomedical, Cole Medical, Cotiviti, Cytiva, Cytosmart Technologies, Entopsis, Federated Healthcare Supply Holdings, Florio, Genetics Institute of America, Healthverity, Horizon Discovery Group, Icecure Medical, Intraop Medical, Itamar Medical, Livanova, Maccabi Healthcare Services, Medtronic, Milestone Scientific, Mimedx Group, Mts Medical Technology, Nexa3D, Nuritas, Qualtrics, Quotient, Sonmol, Sono-Tek, Trividia Health, Vivalnk.
Read More
Pills under magnifying glass

COVID-19 underscores threat of counterfeit antibiotics, antimalarials

April 22, 2020
By Mari Serebrov
No Comments
Recent seizures of fake medical products being marketed in the COVID-19 pandemic underscore the need to curb the growing international trade in counterfeit drugs that’s putting hundreds of thousands of lives at risk, the Organisation for Economic Cooperation and Development (OECD) warned this week.
Read More
2D nanoparticles

Nanobody startup Sysvax aims for COVID-19 cures with three approaches

April 22, 2020
By Elise Mak
No Comments
BEIJING – Nanobody startup Sysvax Inc., with its R&D center in Beijing and manufacturing facilities in Zhongshan, is developing a recombinant protein vaccine and a nanobody therapeutic for COVID-19, while trying to extend the half-life of potential COVID-19 treatments with its expertise in this smallest possible antibody format.
Read More

Regulatory front for April 22, 2020

April 22, 2020
No Comments
The latest global regulatory news, changes and updates affecting biopharma.
Read More

Regulatory actions for April 22, 2020

April 22, 2020
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Algernon, Biontech, Clarity, Janssen, Mallinckrodt, Novartis, Pfizer, Vitro.
Read More

Other news to note for April 22, 2020

April 22, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ablexis, Alkermes, Alpha Cognition, Anticancer, Applied Biomath, Asklepios, Avacta, Bayer Bonus Biogroup, Brainvectis, Caladrius, Cellphire, Cocrystal Pharma, Cormedix, Cyclica, Emergex Vaccines, Envisagenics, Etherna, Evotec, Frame, Gilead, Hoth, Immunic, Johnson & Johnson, Kalos, Kite, Linical, Northern Biologics, Nuritas, Oncology Venture, Onko-innate, Pharnext, Q Biomed, Sanofi, Som, Targovax, Valo, Wize, Wuxi, Zylö Therapeutics.
Read More

In the clinic for April 22, 2020

April 22, 2020
No Comments

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actelion, Astrazeneca, Bluebird, Boehringer, Exelixis, GSK, Harbour, Imbrium, Immutep, Incyte, Intra-Cellular, Kiniksa, Levo, Lilly, Prothena, Neoimmunetech, Regeneron, Regenxbio, Roche, Saniona, Sojournix, Tersera, UCB, United Therapeutics.


Read More

Financings for April 22, 2020

April 22, 2020
No Comments
Biopharmas raising money in public or private financings, including: Actinium, Arcturus, Calithera, Cyclacel, Forx, Myosana, Migvax, Realta Life Sciences, VBI.
Read More
Previous 1 2 … 437 438 439 440 441 442 443 444 445 … 510 511 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 31, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 31, 2023.
  • FDA approved icons and medical professional

    Genmab, Abbvie to join Roche with FDA nod for CD20 bispecific in lymphoma

    BioWorld
    Five months after the first anti-CD20xCD3 T-cell engaging bispecific antibody, Roche Holding AG’s Lunsumio (mosunetuzumab), cleared U.S. FDA approval for...
  • Illustration of pancreas

    Gene therapy to reverse T2D shows proof of concept at ASGCT

    BioWorld
    The most ambitious objective of any treatment is to eradicate the disease, acting on its origin to cure it instead of treating its symptoms. This is the purpose...
  • Clinical data illustration

    Medtronic, Philips, Edwards late-breaking study data spotlighted at EuroPCR

    BioWorld MedTech
    Among the many companies presenting data at the EuroPCR conference in Paris, several late breaking trials from heavy hitters Medtronic plc, Royal Phillips NV and...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing